Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity.

MLA

Sabatino, Joseph J., Jr, et al. “Impact of Multiple Sclerosis Disease-Modifying Therapies on SARS-CoV-2 Vaccine-Induced Antibody and T Cell Immunity.” MedRxiv : The Preprint Server for Health Sciences, Sept. 2021. EBSCOhost, https://doi.org/10.1101/2021.09.10.21262933.

APA

Sabatino, J. J., Jr, Mittl, K., Rowles, W., Mcpolin, K., Rajan, J. V., Zamecnik, C. R., Dandekar, R., Alvarenga, B. D., Loudermilk, R. P., Gerungan, C., Spencer, C. M., Sagan, S. A., Augusto, D. G., Alexander, J., Hollenbach, J. A., Wilson, M. R., Zamvil, S. S., & Bove, R. (2021). Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity. MedRxiv : The Preprint Server for Health Sciences. https://doi.org/10.1101/2021.09.10.21262933

Chicago

Sabatino, Joseph J, Jr, Kristen Mittl, William Rowles, Kira Mcpolin, Jayant V Rajan, Colin R Zamecnik, Ravi Dandekar, et al. 2021. “Impact of Multiple Sclerosis Disease-Modifying Therapies on SARS-CoV-2 Vaccine-Induced Antibody and T Cell Immunity.” MedRxiv : The Preprint Server for Health Sciences, September. doi:10.1101/2021.09.10.21262933.